While alpha-CGRP levels seem to play a key role in migraine pain pathophysiology, as they are increased in patients with active migraine and normalize when treated with CGRP monoclonal antibodies (mAbs), circulating beta-CGRP levels do not change in a series of patients with frequent migraine attacks versus healthy controls [9]. Here, CALCB is linked to migraine disorder.